Rchr
J-GLOBAL ID:201901008903024204   Update date: Apr. 07, 2024

TSUGE MASATAKA

TSUGE MASATAKA
Research field  (1): Gastroenterology
Papers (52):
  • Yosuke Tamura, Atsushi Ono, Hikaru Nakahara, Clair Nelson Hayes, Yasutoshi Fujii, Peiyi Zhang, Masami Yamauchi, Shinsuke Uchikawa, Yuji Teraoka, Takuro Uchida, et al. Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment. Cancers. 2023. 15. 17
  • Sameh A. Gad, Masaya Sugiyama, Masataka Tsuge, Kosho Wakae, Kento Fukano, Mizuki Oshima, Camille Sureau, Noriyuki Watanabe, Takanobu Kato, Asako Murayama, et al. The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. PLOS Pathogens. 2022. 18. 3. e1009983-e1009983
  • Yosuke Suehiro, Masataka Tsuge, Mio Kurihara, Takuro Uchida, Hatsue Fujino, Atsushi Ono, Masami Yamauchi, Grace Naswa Makokha, Takashi Nakahara, Eisuke Murakami, et al. HBV upregulates TRAIL-R3 expression in hepatocytes for escaping both cell apoptosis and suppression of their replication by TRAIL. The Journal of infectious diseases. 2022
  • Haruna Hatooka, Yumi Shimomura, Michio Imamura, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, et al. Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: Anti-HBV PreS1 antibody. The Journal of infection. 2021
  • Yuno Nishida, Michio Imamura, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Tomokazu Kawaoka, et al. Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients. Journal of viral hepatitis. 2021. 28. 9. 1304-1311
more...
MISC (3):
  • 苗代 典昭, 相方 浩, 山上 卓士, 吉松 梨香, 藤野 初江, 菅 宏美, 小林 知樹, 福原 崇之, 本田 洋士, 中原 隆志, et al. 門脈大循環シャントに伴う肝性脳症に対する経静脈的シャント塞栓術の成績. 肝臓. 2014. 55. Suppl.1. A299-A299
  • 小林 知樹, 相方 浩, 菅 宏美, 藤野 初江, 福原 崇之, 苗代 典昭, 大野 敦司, 本田 洋士, 宮木 大輔, 村上 英介, et al. FDG-PETによる小肝細胞癌に対する治療前評価の意義についての検討. 肝臓. 2014. 55. Suppl.1. A386-A386
  • 阿座上 隆広, 高橋 祥一, 木村 友希, 片村 嘉男, 河岡 友和, 實藤 宏美, 平賀 伸彦, 石飛 朋和, 柘植 雅貴, 高木 慎太郎, et al. 急速な食道静脈瘤の増悪を伴った特発性門脈圧亢進症の一例. 日本門脈圧亢進症学会雑誌. 2008. 14. 1. 92-92
Lectures and oral presentations  (7):
  • ADEFOVIR AND LAMIVUDINE CONCENTRATION AND EFFECT OF COMBINATION THERAPY ON LAMIVUDINE RESISTANT HEPATITIS B VIRUS
    (HEPATOLOGY 2009)
  • TELAPREVIR TREATMENT TO A HUMAN HEPATOCYTE CHIMERIC MOUSE WITH GENETICALLY ENGINEERED HEPATITIS C VIRUS INFECTION
    (HEPATOLOGY 2009)
  • ROLE OF APOBEC3A AND APOBEC3B GENES IN CHRONIC HEPATITIS B VIRUS INFECTION
    (HEPATOLOGY 2009)
  • HBX PROTEIN IS NECESSARY FOR HBV REPLICATION IN HUMAN HEPATOCYTES
    (HEPATOLOGY 2008)
  • TELAPREVIR TREATMENT IN COMBINATION WITH INTERFERON-ALPHA TO A HUMAN HEPATOCYTE CHIMERIC MOUSE WITH HEPATITIS C VIRUS INFECTION
    (HEPATOLOGY 2008)
more...
Awards (1):
  • 2007/06 - 広島大学 広仁会 広仁会基礎医学賞 B型肝炎ウイルス感染に伴う肝発癌候補遺伝子の網羅的解析とそのメカニズムの解明
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page